Research Roundup

innovation: candle, tungsten bulb, two modern light bulbs
Debbie Rigby takes a look at the latest research pertinent to community pharmacy Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesIn this double-blind trial, liraglutide, an analogue of human glucagon like peptide 1 (GLP-1), showed a lower rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Ministers welcomed by pharmacy groups
Next Hear this: audio education